News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309 Results
Type
Article (45)
Company Profile (1)
Press Release (263)
Section
Business (116)
Deals (16)
Drug Development (37)
FDA (1)
Job Trends (26)
News (147)
Policy (2)
Tag
Alliances (18)
Alzheimer's disease (1)
Approvals (4)
Artificial intelligence (1)
ASCO (2)
Best Places to Work (23)
Brain cancer (1)
Breast cancer (21)
Cancer (34)
CDC (1)
Clinical research (32)
Collaboration (2)
COVID-19 (2)
C-suite (3)
Cystic fibrosis (1)
Data (20)
Diagnostics (1)
Earnings (51)
Events (84)
Executive appointments (3)
FDA (11)
Funding (1)
Government (2)
Guidances (4)
Healthcare (6)
Immunology and inflammation (1)
Infectious disease (2)
IPO (12)
Job creations (1)
Layoffs (1)
Lung cancer (1)
Lymphoma (5)
Manufacturing (1)
Medical device (1)
Medtech (1)
Mergers & acquisitions (4)
Metabolic disorders (1)
Neurodegenerative disease (3)
Neuroscience (7)
NextGen: Class of 2026 (4)
Now hiring (2)
Obesity (1)
Parkinson's disease (7)
Patient recruitment (1)
People (62)
Pharmaceutical (1)
Phase 1 (20)
Phase 2 (12)
Phase 3 (8)
Pipeline (11)
Policy (1)
Preclinical (14)
Prostate cancer (3)
Radiopharmaceuticals (1)
Rare diseases (2)
Regulatory (6)
Series B (1)
Startups (11)
The Weekly (1)
Vaccines (1)
Venture capital (1)
Date
Last 30 days (2)
Last 365 days (42)
2026 (21)
2025 (49)
2024 (44)
2023 (35)
2022 (34)
2021 (33)
2020 (31)
2019 (21)
2018 (12)
2017 (9)
2016 (8)
2015 (7)
2014 (4)
2013 (1)
Location
Asia (1)
California (5)
Canada (1)
Colorado (1)
Connecticut (59)
Europe (13)
Illinois (1)
Indiana (2)
Massachusetts (6)
New Jersey (1)
New York (11)
North Carolina (1)
Northern California (4)
Pennsylvania (2)
Rhode Island (1)
Texas (1)
United States (80)
309 Results for "arvinas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arvinas to Present at Jefferies Global Healthcare Conference 2026
June 1, 2026
·
2 min read
Press Releases
Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 12, 2026
·
24 min read
Press Releases
Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026
May 5, 2026
·
1 min read
Press Releases
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
May 12, 2026
·
7 min read
Approvals
FDA clears Pfizer, Arvinas’ novel breast cancer therapy despite mixed data
Veppanu, the first PROTAC therapy approved by the FDA, improved progression free survival by 43% versus AstraZeneca’s Faslodex but showed no such significant benefit in the intention-to-treat analysis.
May 4, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
June 4, 2026
·
8 min read
Press Releases
Arvinas to Participate in Upcoming March 2026 Investor Conferences
February 23, 2026
·
1 min read
Press Releases
Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
May 3, 2026
·
13 min read
Press Releases
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
February 24, 2026
·
28 min read
Press Releases
Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 17, 2026
·
1 min read
1 of 31
Next
